Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis

By sjmartinez • April 18, 2024

Beswick DM, Liu CM, Overdevest JB, Zemke A, Khatiwada A, Gudis DA, Miller JE, Kimple A, Tervo JP, DiMango E, Goralski JL, Keating C, Senior B, Stapleton AL, Eshaghian PH, Mace JC, Markarian K, Alt JA, Bodner TE, Chowdhury NI, Getz AE, Hwang PH, Khanwalker A, Lee JT, Li DA, Norris M, Nayak JV, Owens C, Patel ZM, Poch K, Schlosser RJ, Smith KA, Smith TL, Soler ZM, Suh JD, Turner GA, Wang MB, Saavedra MT, Taylor Cousar JL. Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis. Laryngoscope. 2024 Apr 18. doi: 10.1002/lary.31438. Epub ahead of print. PMID: 38634358.

Tags: CFTR modulator therapy, chronic rhinosinusitis, cystic fibrosis, elexacaftor/tezacaftor/ivacaftor, minimal clinically important difference, Publications, Pulmonary, Critical Care & Sleep Medicine

Social Determinants of Health ICD-10 Code Use by a Large Integrated Healthcare System

Hau C, Grubber JM, Ferguson RE, Cushman WC, Ishani A, Glassman PA, Hynes CA, Leatherman SM. Social Determinants of Health ICD-10 Code Use by a[...]

Type 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis

Malone A, Tibbe TD, Turk N, Duru OK, Wisk LE, Mangione C, Page J, Thomas SC, Vu A, Madievsky R, Chon J, Cheng F, Liu[...]

Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia

Ramakrishnan A, Olitsky S, Saggar R, Channick RN, McWilliams JP. Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with[...]